基于素的纳米颗粒加载了克拉里思素,用于改善抗菌和抗癌性能
Walhan Alshaer1, Shrouq Alsotari1,2, Nour Aladaileh1
1Cell Therapy Center, The University of Jordan, Amman 11942, Jordan.
Pharmaceutics
|June 27, 2025
概括
含有克拉里胺的牛血清蛋白纳米颗粒 (CLA-BSA NPs) 显示出增强的抗癌和抗菌特性. 这些纳米粒子有效地向肺癌细胞,并对特定细菌菌株表现出强烈的活性,提供了一个有前途的药物递送系统.
科学领域:
- 纳米医学是一种纳米医学.
- 药物输送系统 药物输送系统
- 抗菌剂 抗菌剂 抗菌剂
背景情况:
- 克拉里斯罗米 (CLA) 是一种抗生素,具有已证明的抗癌活性.
- 优化CLA输送对于增强其治疗潜力至关重要.
- 牛血清专纳米颗粒 (BSA NPs) 提供了一个生物相容的药物输送平台.
研究的目的:
- 开发和表征CLA-装载的BSANP (CLA-BSANP) 进行研究.
- 评估CLA-BSANP的抗癌和抗菌活性.
- 评估CLA-BSANP的药物释放特征和物理化学特性.
主要方法:
- 通过解溶方法合成的CLA-BSANP.
- 使用DLS,FTIR,XRD,TEM和TGA进行表征.
- 在体外释放药物,细胞活力 (MTT) 和抗菌试验 (MIC).
主要成果:
- 通过范德瓦尔斯力证实了CLA-BSANP的相互作用.
- 在还原介质中观察到强大的CLA释放 (50.9%在pH5.0与GSH).
- CLA-BSA NPs对A549肺癌细胞具有显著的抗癌活性,对HDF细胞的毒性最小.
- 有效的抗菌活性对抗细菌大麦 (MIC 0.032μg/mL).
结论:
- CLA-BSA NPs是一个有前途的药物输送系统.
- 证明了CLA增强的抗癌和抗菌功效.
- 优化的纳米粒子改善了CLA的治疗结果.
相关概念视频
Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160


